142 related articles for article (PubMed ID: 32023376)
21. Loss of Epstein-Barr virus-encoded RNA expression in cutaneous dissemination of natural killer/T-cell lymphoma.
Teo WL; Tan SY
J Clin Oncol; 2011 Apr; 29(12):e342-3. PubMed ID: 21282547
[No Abstract] [Full Text] [Related]
22. Hydroa Vacciniforme-like Skin Lesions in Epstein-Barr-Virus-associated T-cell Lymphoproliferation with Subsequent Development of Aggressive NK/T-cell Lymphoma.
Toksoy A; Strifler S; Benoit S; Grigoleit GU; Knop S; Mielke S; Buder-Bakhaya K; Roth S; Goebeler M; Rosenwald A; Geissinger E; Wobser M
Acta Derm Venereol; 2017 Mar; 97(3):379-380. PubMed ID: 27826612
[No Abstract] [Full Text] [Related]
23. [Study on expression of natural killer (NK) cell C-type lectin-like receptors in nasal NK/T-cell lymphomas].
Nong L; Zhang S; Li Y; Zhang Y; Wang Y; Li T
Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):319-24. PubMed ID: 20654155
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the role of Epstein-Barr virus in cases of nodal or extranodal T- and NK-cell lymphoma using eber in situ hybridization.
Karaarslan S; Hekimgil M; Soydan S; Ertan Y; Doğanavşargil B
Pol J Pathol; 2015 Jun; 66(2):161-9. PubMed ID: 26247530
[TBL] [Abstract][Full Text] [Related]
25. Adult patient with Epstein-Barr virus (EBV)-associated lymphoproliferative disorder: chronic active EBV infection or de novo extranodal natural killer (NK)/T-cell lymphoma, nasal type?
Ohtsuka R; Abe Y; Sada E; Kiyasu J; Ashikari A; Shiratsuchi M; Nishimura J; Takayanagi R; Ohshima K
Intern Med; 2009; 48(6):471-4. PubMed ID: 19293549
[TBL] [Abstract][Full Text] [Related]
26. Successful treatment by using a modified SMILE regimen and autologous hematopoietic stem cell transplantation in a pediatric primary EBV-positive nodular NK/T cell lymphoma patient.
Li J; Ye J; Wang Y; Wang J; Fang Y
Ann Hematol; 2022 Feb; 101(2):433-435. PubMed ID: 33580279
[No Abstract] [Full Text] [Related]
27. Extranodal Natural Killer/T-Cell Lymphoma: A Rare Nasal-Type Case.
Sarıbacak Can E; Okutan H; Albayrak M; Han Ü
Turk J Haematol; 2016 Mar; 33(1):74-5. PubMed ID: 27020724
[No Abstract] [Full Text] [Related]
28. Extranodal NK/T-cell lymphoma of the nasal cavity developed in a patient with intestinal Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder.
Furuya G; Abe H; Shinozaki-Ushiku A; Yamashita A; Ihara S; Hirata Y; Chiba A; Fujioka Y; Kurokawa M; Koike K; Fukayama M
Pathol Res Pract; 2018 Jul; 214(7):1051-1055. PubMed ID: 29843925
[TBL] [Abstract][Full Text] [Related]
29. Circulating Epstein-Barr virus-encoded micro-RNAs as potential biomarkers for nasal natural killer/T-cell lymphoma.
Komabayashi Y; Kishibe K; Nagato T; Ueda S; Takahara M; Harabuchi Y
Hematol Oncol; 2017 Dec; 35(4):655-663. PubMed ID: 27709652
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus associated extranodal natural killer T cell lymphoma of nasal type mimicking pyogenic osteomyelitis of the proximal humerus.
Wong T; Ko JY; Wang FS; Chen YJ; Ma MC
Chang Gung Med J; 2008; 31(3):314-9. PubMed ID: 18782956
[TBL] [Abstract][Full Text] [Related]
31. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
[TBL] [Abstract][Full Text] [Related]
32. Primary vitreoretinal natural killer/T-cell lymphoma with breast involvement: A case report and review of the literature.
Gao S; Zhou Y; Jin X; Lin Z; Zhong Y; Shen X
Surv Ophthalmol; 2019; 64(2):225-232. PubMed ID: 30321569
[TBL] [Abstract][Full Text] [Related]
33. [Prognostic value of pretreatment (18)F-FDG PET-CT metabolic parameters in patients with advanced extranodal NK/T cell lymphoma].
Wu LL; Liang JH; Wang L; Xu W; Ding CY
Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):831-836. PubMed ID: 31770850
[No Abstract] [Full Text] [Related]
34. Epstein-barr virus and the pathogenesis of T and NK lymphoma: a mystery unsolved.
George LC; Rowe M; Fox CP
Curr Hematol Malig Rep; 2012 Dec; 7(4):276-84. PubMed ID: 22983913
[TBL] [Abstract][Full Text] [Related]
35. Concurrent Epstein-Barr virus associated NK/T cell lymphoma after immunosuppressive therapy for aplastic anemia: report of a case and review of literature.
Yin G; Ni Y; Xiao Z; He G; Miao K
Int J Clin Exp Pathol; 2015; 8(6):7588-93. PubMed ID: 26261674
[TBL] [Abstract][Full Text] [Related]
36. [Natural killer cell lymphoma in lymph node: report of a case].
Wang GP; Wang SS; Zheng XD; Xie JL; Lü BB; Zhou XG
Zhonghua Bing Li Xue Za Zhi; 2010 Aug; 39(8):561-2. PubMed ID: 21055040
[No Abstract] [Full Text] [Related]
37. Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK/T cell lymphoma is associated with better prognosis.
Kim WY; Jung HY; Nam SJ; Kim TM; Heo DS; Kim CW; Jeon YK
Virchows Arch; 2016 Nov; 469(5):581-590. PubMed ID: 27595782
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders.
Park S; Ko YH
J Dermatol; 2014 Jan; 41(1):29-39. PubMed ID: 24438142
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis and management of extranodal NK/T cell lymphoma nasal type.
Tse E; Kwong YL
Expert Rev Hematol; 2016 Sep; 9(9):861-71. PubMed ID: 27347812
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of standardized uptake value on F18-FDG PET/CT in patients with extranodal nasal type NK/T cell lymphoma: A multicenter, retrospective analysis.
Pak K; Kim BS; Kim K; Kim IJ; Jun S; Jeong YJ; Shim HK; Kim SD; Cho KS
Am J Otolaryngol; 2018; 39(1):1-5. PubMed ID: 29056243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
